Skip to content
Recall Observatory FDA recall evidence

Drug product

Irinotecan Hydrochloride Injection, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial per carton, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Schiffgraben 23, 38690 Vienenburg, Germany; Distributed by: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA, NDC 0143-9702-01.

D-66447-001

September 23, 2013

Class II

Product summary

Firm
West-Ward Pharmaceutical Corp.
Event
Event 66447
Status
Terminated
Classification
Class II
Quantity
9020 vials
Official record key
drug-enforcement:D-66447-001

Official wording

Reason: Superpotent Drug: a recent review of the USP revealed that an incorrect calculation was used to determine the amount of irinotecan to use in formulation which will result in an assay higher than the labeled claim.

Code information: Lot #: AC0020, Exp 03/14; AC0023, AC0025, Exp 08/14

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent